Immunohistochemical expression of androgen receptor in cutaneous basal cell carcinoma

Authors

  • Vladimír Bartoš Department of Pathology, Faculty Hospital in Žilina, Slovakia
  • Milada Kullová Department of Dermatology, Faculty Hospital in Žilina, Slovakia

Keywords:

Basal cell carcinoma, androgen receptor, histologic subtypes

Abstract

Background Androgen receptor (AR) is known to be expressed in a variety of skin tumors, including basal cell carcinoma (BCC). The aim of this study was to investigate an expression status of AR by immunohistochemistry in a set of cutaneous BCC. Material and Methods The study group consisted of 54 BCCs from 49 patients. Based on histomorphology, BCC subtypes were merged into non-aggressive (superficial and nodular subtypes) and aggressive (nodular-infiltrative and infiltrative subtypes) subgroups. Specific monoclonal antibody against AR was used for immunostaining. Results AR was expressed in 32 BCCs (59.3%). In superficial, nodular, nodular-infiltrative and infiltrative BCC subtypes, nuclear reactivity for AR was found in 70% (7/10), 73.1% (19/26), 35.7% (5/14) and 25% (1/4), respectively. A wide quantitative range of AR expression (1–90% of tumor tissue) was seen. There were twenty-seven cases (84.4%) with focal staining and five cases (15.6%) with diffuse staining. There was significantly lower rate of AR expression in BCCs exhibiting aggressive histomorphologic phenotype. No correlation between AR expression and anatomic location and gender was found. Conclusion Although cutaneous BCC is generally considered to be AR-positive neoplasm, in the present study, immunoreactivity for AR was detected only in about half of the cases. Most AR-positive tumors showed only focal staining. The pathologists should be aware of these findings, which may cause difficulties in distinguishing BCC from related AR-negative epithelial skin tumors. 

References

Gao W, Bohl CE, Dalton JT. Chemistry and structural biology of androgen receptor. Chem Rev 2005; 105: 3352-70.

Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992; 133: 467-75.

Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 1999; 21: 426-31.

Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J 2005; 52: 317-325.

Astarci HM, Gurbuz GA, Sengul D et al. Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma. Oncol Lett 2015; 10: 3466-3470.

Izikson L, Bhan A, Zembowicz A. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors. Am J Dermatopathol 2005; 27: 91–95.

Katona TM, Perkins SM, Billings SD. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma? J Cutan Pathol 2008; 35: 174–79.

Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R, Shahsiah R. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. Am J Clin Pathol 2010; 134: 22–26.

Costache M, Bresch M, Böer A. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: A critical reappraisal of histomorphological and immunohistochemical criteria for differentiation. Histopathology 2008; 52: 865–76.

Arits AH, Van Marion AM, Lohman BG, et al. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview. Eur J Dermatol 2011; 21: 870-3.

Lee YF, Chang YT, Liu HN. Differentiating basal cell carcinoma from trichoepithelioma by using androgen receptor expression. Dermatol Sinica 2009; 27: 154-60.

Ahmed NAA, Ahmed NS. Androgen receptor and CD10 expression in differential diagnosis of trichoepithelioma and basal cell carcinoma. Al-Azhar Assiut Med J 2011; 9: 151-160.

Senghal VN, Chatterjee K, Pandhi D, Khurana A. Basal cell carcinoma: pathophysiology. Skinmed 2014; 12: 176-81.

Downloads

Published

2019-10-21

How to Cite

1.
Bartoš V, Kullová M. Immunohistochemical expression of androgen receptor in cutaneous basal cell carcinoma. J Pak Assoc Dermatol [Internet]. 2019Oct.21 [cited 2024Nov.4];29(3):316-21. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1299

Issue

Section

Original Articles